Fed up with the healthcare industry, this red state capped insulin prices for patients

by | Nov 16, 2026 | Health

Fed up with the healthcare industry, this red state capped insulin prices for patients

North Dakota has enacted legislation capping patients’ monthly out-of-pocket insulin costs at $25, joining 29 states with similar measures as part of a growing movement to address escalating drug prices. The policy caps what patients must pay monthly for insulin regardless of their deductible status, though other healthcare expenses remain subject to standard cost-sharing arrangements.

The initiative emerged from mounting pressure to address insulin affordability, with patient advocates citing documented cases of individuals rationing or forgoing the medication due to cost. Among the estimated 40 million Americans with diabetes, approximately one-fifth depend on insulin. Federal data showed that average yearly out-of-pocket costs for insulin reached $470 annually in 2018 for those with private health insurance, though this figure declined to $220 by 2025 as drug manufacturers faced public scrutiny.

The effort has attracted unusual bipartisan support. North Dakota state Sen. Sean Cleary, a Republican who co-sponsored the legislation, noted that the market for insulin had ceased functioning effectively for consumers, creating consensus beyond traditional ideological divisions. The measure followed Colorado becoming the first state to enact an insulin copay cap in 2019, capping costs at $100 for a 30-day supply under state-regulated plans. At the federal level, President Biden signed legislation in 2022 capping insulin for Medicare recipients at $35 monthly, though efforts to extend similar protections to privately insured Americans stalled due to Republican opposition.

In North Dakota, opposition from health insurers and the state chamber of commerce cited concerns that price controls would result in higher premiums for all enrollees. Industry representatives and some lawmakers questioned whether government intervention was appropriate, though patient advocates and families testifying at the Capitol provided persuasive accounts of the medication’s necessity and the financial burden it imposed on households already managing serious chronic illness.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI